---
figid: PMC7980145__gr5
figlink: pmc/articles/PMC7980145/figure/fig5/
number: Fig. 5
caption: (A) Mechanism of macromolecular prodrugs inhibiting viruses []. (B) Ribavirin
  acrylate monomer is synthesized via a chemotaxis pathway (top). RAFT controlled
  the copolymerization of RBV acrylate with N-vinylpyrrolidone (NVP) to provide a
  macromolecular precursor for RBV (bottom). Phthalimidomethyl-O-ethyl xanthate was
  used as an RAFT agent []. (C) Synthesis of ribavirin (RBV( methacrylate and macromolecular
  prodrugs for RBV based on HPMA []. (D) Proposed synthesis of macromolecular prodrugs
  of RBV. The polymerizable acrylate of RBV was synthesized by a chemoenzymatic method
  using Nz435/CAL-B in dioxane (i) for RAFT polymerization and AA as a co-monomer
  to obtain a macromolecular precursor (ii). The synthesized polymer released the
  original RBV on hydrolysis (iii) []. (E) Structures of polyanionic macromolecular
  prodrugs of ribavirin based on these polymers, whereby RBV is conjugated to the
  polymer via an ester linkage or a disulfide linkage to achieve ultrafast intracellular
  drug release [].
pmcid: PMC7980145
papertitle: 'Toward the prevention of coronavirus infection: what role can polymers
  play?.'
reftext: X. Jiang, et al. Mater Today Adv. 2021 Mar 20 ;10:100140-100140.
pmc_ranked_result_index: '13413'
pathway_score: 0.9028354
filename: gr5.jpg
figtitle: ' Mechanism of macromolecular prodrugs inhibiting viruses '
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7980145__gr5.html
  '@type': Dataset
  description: (A) Mechanism of macromolecular prodrugs inhibiting viruses []. (B)
    Ribavirin acrylate monomer is synthesized via a chemotaxis pathway (top). RAFT
    controlled the copolymerization of RBV acrylate with N-vinylpyrrolidone (NVP)
    to provide a macromolecular precursor for RBV (bottom). Phthalimidomethyl-O-ethyl
    xanthate was used as an RAFT agent []. (C) Synthesis of ribavirin (RBV( methacrylate
    and macromolecular prodrugs for RBV based on HPMA []. (D) Proposed synthesis of
    macromolecular prodrugs of RBV. The polymerizable acrylate of RBV was synthesized
    by a chemoenzymatic method using Nz435/CAL-B in dioxane (i) for RAFT polymerization
    and AA as a co-monomer to obtain a macromolecular precursor (ii). The synthesized
    polymer released the original RBV on hydrolysis (iii) []. (E) Structures of polyanionic
    macromolecular prodrugs of ribavirin based on these polymers, whereby RBV is conjugated
    to the polymer via an ester linkage or a disulfide linkage to achieve ultrafast
    intracellular drug release [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCAR2
  - BLOC1S4
  - Diosane
  - AIBN
  - DMSO
  - RBV-acrylate
  - OHD
  - PMAA-Ribavirin
  - disulfide
  - PAA-Ribavirin
  - ester
  - OHD
genes:
- word: Net35
  symbol: NET35
  source: hgnc_alias_symbol
  hgnc_symbol: CCAR2
  entrez: '57805'
- word: CNO
  symbol: CNO
  source: hgnc_prev_symbol
  hgnc_symbol: BLOC1S4
  entrez: '55330'
chemicals:
- word: Diosane
  source: ''
  identifier: ''
- word: AIBN
  source: MESH
  identifier: C004526
- word: DMSO
  source: MESH
  identifier: D004121
- word: RBV-acrylate
  source: MESH
  identifier: C111247
- word: OHD
  source: MESH
  identifier: C035993
- word: PMAA-Ribavirin
  source: MESH
  identifier: D012254
- word: disulfide
  source: MESH
  identifier: D004220
- word: PAA-Ribavirin
  source: MESH
  identifier: D012254
- word: ester
  source: MESH
  identifier: D004952
diseases:
- word: OHD
  source: MESH
  identifier: C536209
---
